Medical Devices Investors & VC Firms in Japan
75 firms in this list, with a median first check of $1M. 9 of them lead rounds. Generated from verified public data and updated continuously.
UTokyo Innovation Platform Co. Ltd.
TokyoPre-Seed–Growth
25 people
Incubate Fund
TokyoPre-Seed–Growth$314K – $91M
64 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
19 people
Nippon Venture Capital
TokyoPre-Seed–Late Stage$1.5M – $269M
SMBC Venture Capital
TokyoPre-Seed–Late Stage$2.3M – $269M
27 people
Beyond Next Ventures
TokyoSeed–Series A
38 people
Taiwania Capital
TaipeiSeed–Growth$3M – $85M
43 people
OSAKA University Venture Capital
OsakaPre-Seed–Growth$3M – $142M
20 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
39 people
Fortune Venture Capital
ShenzhenSeed–Late Stage$425K – $73M
11 people
UntroD Capital
TokyoPre-Seed–Growth$772K – $241M
5 people
ARCHIMED Japan
LyonGrowth–Late Stage$10.8M – $1.1B
22 people
UTEC
TokyoPre-Seed–Growth$3.1M – $78M
1 person
GoAhead Ventures
Menlo ParkPre-Seed–Series A$500K – $1M
3 people
Mitsui Global Investment
Menlo ParkPre-Seed–Late Stage$500K – $10M
14 people
Angel Bridge Co.,Ltd.
TokyoPre-Seed–Growth$792K – $62M
9 people
IT-Farm Corporation
TokyoSeed–Series A
1 person
Remiges Ventures, Inc.
SeattlePre-Seed–Seed
22 people
Catalys Pacific
TokyoSeed–Series A
25 people
Hiroshima Venture Capital Co. Ltd.
HiroshimaPre-Seed–Late Stage
Vertex Ventures China
SingaporePre-Seed–Late Stage$2M – $85M
6 people
Fast Track Initiative
TokyoPre-Seed–Growth$1.2M – $184M
2 people
MedTech Actuator
Seed–Series B
Samsung Ventures
Menlo ParkSeed–Late Stage
26 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.

















































